1月21日，大湖股份盘中上涨2.08%，截至13:04，报7.85元/股，成交1.48亿元，换手率3.98%，总市值 37.78亿元。 大湖股份所属申万行业为：农林牧渔-渔业-水产养殖。所属概念板块包括：小盘、电子商务、养老产 业、污水处理、民营医院等。 截至11月20日，大湖股份股东户数4.21万，较上期增加0.00%；人均流通股11438股，较上期增加 0.00%。2025年1月-9月，大湖股份实现营业收入6.45亿元，同比减少15.69%；归母净利润-56.56万元， 同比增长97.36%。 分红方面，大湖股份A股上市后累计派现4417.56万元。近三年，累计派现0.00元。 机构持仓方面，截止2025年9月30日，大湖股份十大流通股东中，诺安多策略混合A（320016）位居第 三大流通股东，持股256.75万股，为新进股东。金元顺安元启灵活配置混合（004685）位居第四大流通 股东，持股256.40万股，相比上期增加40.50万股。 责任编辑：小浪快报 资金流向方面，主力资金净流出888.74万元，特大单买入718.78万元，占比4.86%，卖出792.24万元，占 比5.36%；大单买入3419. ...

通策医疗所属申万行业为：医药生物-医疗服务-医院。所属概念板块包括：辅助生殖、DeepSeek概念、 民营医院、区块链、口腔医疗等。 通策医疗今年以来股价涨12.41%，近5个交易日涨4.15%，近20日涨10.19%，近60日涨6.60%。 资料显示，通策医疗股份有限公司位于杭州市西湖区西溪路双口井巷1号通策医疗大厦，成立日期1995 年8月30日，上市日期1996年10月30日，公司主营业务涉及医疗服务投资及口腔医疗服务。主营业务收 入构成为：医疗服务92.84%，产品销售4.06%，建筑工程2.72%，其他0.38%。 机构持仓方面，截止2025年9月30日，通策医疗十大流通股东中，华宝中证医疗ETF（512170）位居第 三大流通股东，持股888.54万股，相比上期减少158.04万股。南方中证500ETF（510500）位居第五大流 通股东，持股456.41万股，相比上期减少10.67万股。广发聚瑞混合A（270021）位居第六大流通股东， 持股337.66万股，持股数量较上期不变。广发盛兴混合A（011136）位居第七大流通股东，持股321.41 万股，为新进股东。香港中央结算有限公司位居第八大流 ...

新华医疗所属申万行业为：医药生物-医疗器械-医疗设备。所属概念板块包括：人脑工程（脑机接 口）、民营医院、医疗器械、合成生物、人工智能等。 截至9月30日，新华医疗股东户数3.87万，较上期减少1.44%；人均流通股15610股，较上期增加1.46%。 2025年1月-9月，新华医疗实现营业收入69.78亿元，同比减少6.00%；归母净利润4.34亿元，同比减少 29.61%。 分红方面，新华医疗A股上市后累计派现9.63亿元。近三年，累计派现6.07亿元。 机构持仓方面，截止2025年9月30日，新华医疗十大流通股东中，华宝中证医疗ETF（512170）位居第 三大流通股东，持股1373.28万股，相比上期减少236.04万股。香港中央结算有限公司位居第四大流通股 东，持股868.91万股，相比上期增加76.89万股。国联优势产业混合A（014329）位居第七大流通股东， 持股486.61万股，为新进股东。南方中证1000ETF（512100）位居第八大流通股东，持股443.44万股， 为新进股东。 1月21日，新华医疗盘中上涨2.05%，截至10:29，报16.42元/股，成交1.20亿元，换手率1.22 ...

Group 1 - The core viewpoint of the news is that Dahu Co., Ltd. has experienced fluctuations in stock price and financial performance, with a notable increase in stock price year-to-date but a decline in revenue for the recent period [1][2]. - As of January 19, Dahu's stock price increased by 2.02% to 7.58 CNY per share, with a total market capitalization of 3.648 billion CNY [1]. - The company has seen a year-to-date stock price increase of 20.70%, while it has experienced a slight decline of 0.39% over the last five trading days [1]. Group 2 - For the period from January to September 2025, Dahu Co., Ltd. reported a revenue of 645 million CNY, which represents a year-on-year decrease of 15.69% [2]. - The net profit attributable to the parent company for the same period was -565,600 CNY, showing a significant year-on-year increase of 97.36% [2]. - Dahu Co., Ltd. has not distributed any dividends in the last three years, with a total payout of 44.1756 million CNY since its A-share listing [3]. Group 3 - The company operates primarily in health product manufacturing and sales, with revenue contributions from various segments: 45.76% from aquatic products, 42.99% from medical services, 9.45% from liquor, and minor contributions from rental and other businesses [1]. - As of November 20, 2025, the number of shareholders for Dahu Co., Ltd. was 42,100, with an average of 11,438 circulating shares per shareholder [2]. - Notable institutional holdings include Nuoan Multi-Strategy Mixed Fund, which is the third-largest shareholder with 2.5675 million shares, and Jinyuan Shun'an Yuanqi Flexible Allocation Mixed Fund, which increased its holdings by 405,000 shares [3].

1月19日，通策医疗盘中上涨2.01%，截至10:24，报45.73元/股，成交2.74亿元，换手率1.36%，总市值 204.55亿元。 资金流向方面，主力资金净流入826.25万元，特大单买入743.27万元，占比2.71%，卖出492.62万元，占 比1.80%；大单买入5494.17万元，占比20.06%，卖出4918.57万元，占比17.96%。 通策医疗今年以来股价涨13.73%，近5个交易日涨8.01%，近20日涨11.37%，近60日涨8.39%。 分红方面，通策医疗A股上市后累计派现3.92亿元。近三年，累计派现3.40亿元。 机构持仓方面，截止2025年9月30日，通策医疗十大流通股东中，华宝中证医疗ETF（512170）位居第 三大流通股东，持股888.54万股，相比上期减少158.04万股。南方中证500ETF（510500）位居第五大流 通股东，持股456.41万股，相比上期减少10.67万股。广发聚瑞混合A（270021）位居第六大流通股东， 持股337.66万股，持股数量较上期不变。广发盛兴混合A（011136）位居第七大流通股东，持股321.41 万股，为新进股东。香港中央结算 ...

Core Viewpoint - Xinhua Medical experienced a stock price decline of 2.02% on January 15, with a current price of 16.46 yuan per share and a total market capitalization of 9.985 billion yuan. The company has seen a year-to-date stock price increase of 14.31% but a slight decline of 0.30% over the last five trading days [1]. Group 1: Financial Performance - For the period from January to September 2025, Xinhua Medical reported a revenue of 6.978 billion yuan, reflecting a year-on-year decrease of 6.00%. The net profit attributable to shareholders was 434 million yuan, down 29.61% compared to the previous year [2]. - The company has distributed a total of 9.63 billion yuan in dividends since its A-share listing, with 607 million yuan distributed over the last three years [3]. Group 2: Shareholder and Market Activity - As of September 30, 2025, the number of shareholders for Xinhua Medical was 38,700, a decrease of 1.44% from the previous period. The average number of circulating shares per person increased by 1.46% to 15,610 shares [2]. - The top ten circulating shareholders include notable entities such as Huabao Zhongzheng Medical ETF, which holds 13.7328 million shares, a decrease of 2.3604 million shares from the previous period. Hong Kong Central Clearing Limited increased its holdings by 768,900 shares to 8.6891 million shares [3].

Core Viewpoint - Tonghua Jinma's stock price has shown volatility, with a recent increase of 2.14% but a year-to-date decline of 1.16%, indicating potential challenges in the market [1]. Financial Performance - For the period from January to September 2025, Tonghua Jinma reported revenue of 892 million yuan, a year-on-year decrease of 7.88%, while net profit attributable to shareholders was 24.96 million yuan, reflecting a growth of 4.35% [2]. - Cumulative cash dividends since the A-share listing amount to 210 million yuan, with no dividends paid in the last three years [3]. Shareholder Structure - As of September 30, 2025, the number of shareholders decreased by 3.20% to 38,200, while the average number of circulating shares per person increased by 3.31% to 25,266 shares [2]. - The top ten circulating shareholders include notable entities such as Innovation Drug and Southern CSI 1000 ETF, with changes in their holdings indicating shifts in investor sentiment [3].

Group 1 - The core business of the company includes retail of department stores and home appliances, food production and sales, real estate development and sales, and healthcare services, with healthcare services accounting for 79.22% of total revenue [2] - As of September 30, the number of shareholders decreased by 11.89% to 62,600, while the average circulating shares per person increased by 13.49% to 14,139 shares [2] - For the period from January to September 2025, the company reported a revenue of 2.645 billion yuan, a year-on-year decrease of 4.21%, and a net profit attributable to shareholders of 55.6589 million yuan, down 44.80% year-on-year [2] Group 2 - The company's stock price has increased by 0.75% year-to-date, but has decreased by 4.98% in the last five trading days [1] - The company has appeared on the "Dragon and Tiger List" three times this year, with the most recent appearance on November 17, where it recorded a net buy of -9.7711 million yuan [1] - Cumulative cash dividends since the company's A-share listing amount to 2.386 billion yuan, with 141 million yuan distributed in the last three years [3]

截至9月30日，通化金马股东户数3.82万，较上期减少3.20%；人均流通股25266股，较上期增加3.31%。 2025年1月-9月，通化金马实现营业收入8.92亿元，同比减少7.88%；归母净利润2496.35万元，同比增长 4.35%。 分红方面，通化金马A股上市后累计派现2.10亿元。近三年，累计派现0.00元。 机构持仓方面，截止2025年9月30日，通化金马十大流通股东中，创新药（159992）位居第七大流通股 东，持股919.30万股，相比上期增加8.78万股。南方中证1000ETF（512100）位居第八大流通股东，持 股884.16万股，相比上期减少9.23万股。香港中央结算有限公司位居第九大流通股东，持股726.71万 股，相比上期减少150.84万股。华夏中证1000ETF（159845）位居第十大流通股东，持股525.31万股， 为新进股东。 今年以来通化金马已经2次登上龙虎榜，最近一次登上龙虎榜为9月11日，当日龙虎榜净买入1.42亿元； 买入总计5.44亿元 ，占总成交额比29.22%；卖出总计4.02亿元 ，占总成交额比21.59%。 资料显示，通化金马药业集团股份有限公司位于吉 ...

资料显示，永和流体智控股份有限公司位于浙江省台州市玉环市清港镇工业产业集聚区，成立日期2003 年8月28日，上市日期2016年4月28日，公司主营业务涉及医疗健康产业、流体智控业务。主营业务收入 构成为：阀门管件类89.41%，医疗服务及其他产业10.57%，光伏电池片0.02%。 永和智控所属申万行业为：机械设备-通用设备-金属制品。所属概念板块包括：出海概念、小盘、抗癌 治癌、微盘股、民营医院等。 12月22日，永和智控盘中上涨2.01%，截至10:59，报6.59元/股，成交1.09亿元，换手率3.87%，总市值 29.38亿元。 资金流向方面，主力资金净流出2006.10万元，特大单买入0.00元，占比0.00%，卖出567.99万元，占比 5.19%；大单买入2462.84万元，占比22.51%，卖出3900.95万元，占比35.65%。 永和智控今年以来股价涨61.52%，近5个交易日涨0.61%，近20日涨6.46%，近60日涨37.87%。 今年以来永和智控已经1次登上龙虎榜，最近一次登上龙虎榜为8月6日，当日龙虎榜净买入-3169.93万 元；买入总计4976.82万元 ，占总成交额比6. ...